Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Recruiting · NCT04073290 · Registry updated 2025-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension | Recruiting | Phase 4 | 2025-01-28 | NCT04073290 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Academic Medical Centre | Amsterdam | Netherlands | 1 |
| Erasmus Medical Center | Rotterdam | Netherlands | 36 |
| Leiden University Medical Center | Leiden | Netherlands | 54 |
| Radboud University | Nijmegen | Netherlands | 4 |
| Universitaire Ziekenhuizen Leuven | Leuven | Belgium | 10 |
| University Medical Center Groningen | Groningen | Netherlands | 66 |